About Just Biotherapeutics
Just Biotherapeutics is a company based in Seattle (United States) founded in 2014 was acquired by Evotec in May 2019.. Just Biotherapeutics has raised $123.51 million across 4 funding rounds from investors including Merck, Evotec and BOC. The company has 79 employees as of December 31, 2017. Just Biotherapeutics offers products and services including Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services. Just Biotherapeutics operates in a competitive market with competitors including Alexion, argenx, BigHat, Kodiak Sciences and Visterra, among others.
- Headquarter Seattle, United States
- Employees 79 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Just Biotherapeutics
Just Biotherapeutics offers a comprehensive portfolio of products and services, including Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for efficient biologics production using automated processes.
Services for antibody discovery and biomanufacturing from start to finish.
End-to-end solutions for clinical and commercial biologics supply.
Funding Insights of Just Biotherapeutics
Just Biotherapeutics has successfully raised a total of $123.51M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $35.0M
-
First Round
First Round
(18 Sep 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Series B - Just Biotherapeutics | Valuation | Hillhouse | |
| Aug, 2017 | Amount | Series B - Just Biotherapeutics | Valuation | Temasek | |
| Jul, 2016 | Amount | Series A - Just Biotherapeutics | Valuation | Gates Foundation |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Just Biotherapeutics
Just Biotherapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, Evotec and BOC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Just Biotherapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Just Biotherapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Just Biotherapeutics Comparisons
Competitors of Just Biotherapeutics
Just Biotherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alexion, argenx, BigHat, Kodiak Sciences and Visterra, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for rare and devastating diseases are developed by Alexion.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
Therapeutics for retinal diseases are developed by the company.
|
|
| domain | founded_year | HQ Location |
Developer of monoclonal antibodies against infectious diseases
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs for primary myopathies are developed and targeted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Just Biotherapeutics
Frequently Asked Questions about Just Biotherapeutics
When was Just Biotherapeutics founded?
Just Biotherapeutics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Just Biotherapeutics located?
Just Biotherapeutics is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Just Biotherapeutics a funded company?
Just Biotherapeutics is a funded company, having raised a total of $123.51M across 4 funding rounds to date. The company's 1st funding round was a Series A of $14M, raised on Sep 18, 2015.
How many employees does Just Biotherapeutics have?
As of Dec 31, 2017, the latest employee count at Just Biotherapeutics is 79.
What does Just Biotherapeutics do?
Just Biotherapeutics was founded in 2014 in Seattle, United States, within the biotechnology sector. Focus is placed on integrating protein design, process design, and manufacturing plant design to speed up clinical translation and cut costs in biotherapeutics. Services offered include molecular design, process design, drug product design, and plant design, supporting efficient development from concept to production.
Who are the top competitors of Just Biotherapeutics?
Just Biotherapeutics's top competitors include argenx, Kodiak Sciences and MacroGenics.
What products or services does Just Biotherapeutics offer?
Just Biotherapeutics offers Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services.
Who are Just Biotherapeutics's investors?
Just Biotherapeutics has 12 investors. Key investors include Merck, Evotec, BOC, Gates Foundation, and Temasek.